{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.58G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "58"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "c.58G>A (p.E46K)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0004972"
  },
  "Experiment Method": [
    {
      "Assay Method": "Planar lipid bilayers and Langmuir monolayer techniques",
      "Material used": {
        "Material Source": "In vitro phosphatidylcholine bilayers with added gangliosides (GM3 or GM1)",
        "Material Name": "Synthetic phosphatidylcholine bilayers",
        "Description": "The study utilized synthetic phosphatidylcholine bilayers reconstituted with purified α-Synuclein mutants and varying concentrations of gangliosides."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.58G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "altered ion channel formation",
          "Result Description": "The E46K mutant exhibited significantly reduced conductance compared to wild-type α-Synuclein in the presence of GM3, while GM1 showed no such effect."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "No information provided on biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "No information provided on technical replicates."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "No basic positive control described in the study."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "No basic negative control described in the study."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal conductance levels were inferred based on wild-type α-Synuclein behavior.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal conductance levels were defined by significantly reduced ion flux compared to wild-type under similar conditions.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Planar lipid bilayer techniques are commonly used to study membrane protein function and ion channel activity, making this approach suitable for studying α-Synuclein in the context of Parkinson's disease."
      }
    }
  ]
}